Try GOLD - Free

Pharma deals soaring, but top drugmakers hold back

Mint Mumbai

|

October 09, 2025

Dealmaking in India’s pharma sector has surged over the past two years as companies seek to beef up their portfolios and reduce reliance on the US market.

- jessica jani

Yet, some of the largest drugmakers with billions in cash are holding back.

Sun Pharmaceutical Industries Ltd, Cipla Ltd and Dr Reddy's Laboratories Ltd that have a strong US focus are striking fewer acquisitions and partnerships as they look for new markets, according to industry experts. On the other hand, pharma companies with a strong India focus have ramped up their dealmaking.

In July, Torrent Pharmaceuticals Ltd acquired a 46.39% in Mumbai-based JB Chemicals and Pharmaceuticals Ltd for %11,917 crore. In October last year, Mankind Pharma Ltd bought Bengaluru-based Bharat Serums and Vaccines Ltd for 213,768 crore.

Sun Pharma, Cipla, and Dr Reddy's—which derive 30-45% of their revenue from selling mostly copycat or generic drugs to the US—are employing a more measured approach even as they sit on large piles of cash. Torrent and Mankind earn 51-55% of their business from India.

MORE STORIES FROM Mint Mumbai

Mint Mumbai

America should think before it slams its door on immigration

The benefits of it are subtle but compelling enough to keep it going

time to read

3 mins

October 09, 2025

Mint Mumbai

Mint Mumbai

Fintechs must design for all, says RBI governor

increase transparency and awareness in consent management and data sharing under the account aggregator framework,\" he said.

time to read

1 mins

October 09, 2025

Mint Mumbai

Road builders sweat as highway tenders dry up

After a prolonged slowdown in orders, India's road construction giants are keeping their fingers crossed for a long-awaited revival.

time to read

2 mins

October 09, 2025

Mint Mumbai

Competitive exams in India: Are we testing the right parameters?

Their focus is on skills that often have nothing to do with requirements of the actual roles on offer

time to read

3 mins

October 09, 2025

Mint Mumbai

JSW tweaks auto top deck before EV, truck launch

Sajjan Jindal-led JSW Group has introduced a series of changes to the boards of at least two ofits auto companies and changed the holding company of its component business between August and September, as the conglomerate gears up to launch cars and trucks next financial year.

time to read

2 mins

October 09, 2025

Mint Mumbai

Mint Mumbai

India pulls several anti-dumping levies on China, others

New Delhi has quietly allowed the expiry of anti-dumping duties on a range of goods from several countries including China, signalling a recalibration in its approach to trade protection.

time to read

2 mins

October 09, 2025

Mint Mumbai

Ombudsman rules, but are health insurers playing fair?

How to enforce ombudsman awards, challenge cancellations, ensure uninterrupted coverage

time to read

4 mins

October 09, 2025

Mint Mumbai

Mint Mumbai

Design products accessible to all, RBI governor tells fintechs

Fintechs in India have a clear mandate from the head of the country's central bank: design products that are accessible, inclusive, and tailored for underserved populations.

time to read

2 mins

October 09, 2025

Mint Mumbai

Mint Mumbai

Airtel's chief flags regulatory overreach in telecom sector

Telcos face disproportionate regulatory burden compared to other digital players, Vittal said

time to read

2 mins

October 09, 2025

Mint Mumbai

Mint Mumbai

Advertisers push for transparency standards in ad sales

Some of the advertising industry's largest players have joined forces to propose new standards for transparency in the digital auctions that increasingly dominate ad sales.

time to read

4 mins

October 09, 2025

Listen

Translate

Share

-
+

Change font size